the involvement of miRNAs in the AF-induced I Ca,L downregulation. In this line, miR-1 and miR-328 bind 3′UTR of CACNA1C and decrease I Ca,L . 9, 10 Expression of miR-21 is increased in plasma samples from patients with chronic AF (CAF) compared with patients in sinus rhythm (SR). 11 Moreover, Adam et al, 12 showed a 2.5-fold upregulation of miR-21 expression in left atrial appendages from patients with CAF relative to patients in SR. They proposed that miR-21 could participate in atrial fibrosis formation and contribute to the AF-induced structural remodeling. 12, 13 Indeed, miR-21 is highly expressed in cardiac fibroblasts, where it is implicated in the activation of profibrotic pathways 14 and atrial profibrillatory remodeling in experimental models of heart failure. 15 However, expression of miR-21 in cardiac myocytes has not been consistently demonstrated, and its putative effects on the electrical remodeling are currently unknown. We hypothesized that miR-21 is expressed in human atrial myocytes and upregulated in myocytes from patients with CAF compared with those in SR, playing a role in the CAF-induced I Ca,L decrease. Therefore, this study was undertaken to compare the expression of miR-21 in isolated myocytes from atrial appendages obtained from patients in SR and with CAF and to analyze whether Ca 2+ channel subunits are targets for miR-21.
Methods
The study was approved by the Investigation Committee of the Hospital Universitario Gregorio Marañón (CNIC-13) and conforms to the principles outlined in the Declaration of Helsinki. Each patient gave written informed consent. Clinical data of the patients are included in Table I in the Data Supplement.
Analysis of the mRNA Expression in Human Atrial Myocytes

Real-Time Quantitative Polymerase Chain Reaction
RNA was extracted with miRNeasy Micro Kit (Qiagen, UK) from human atrial myocytes enzymatically isolated from right atrial appendages obtained from patients in SR (n=10) and with CAF (n=10) as described. 5, 16 From each sample, 2 RNA fractions were obtained: a large RNA (>200 nucleotides) fraction and a separate miRNA-enriched fraction. Quantitative polymerase chain reaction (qPCR) was performed using TaqMan gene and miRNA expression assays (Life Technologies, USA). The cycle to threshold (C t ) values were normalized to 18S rRNA.
miRNA Target Prediction
Computational prediction of putative targets for miR-21 was performed by using DIANA-microT3.1, TargetMiner, PicTar, mi-RANDA, TargetScan6.2, EIMMo, and RNA22-HSA miRNA target prediction algorithms.
Luciferase Gene Expression Reporter Assay
Luciferase activity assays were performed in Chinese Hamster Ovary (CHO) cells transfected with the 3′UTR regions of CACNA1C, CACNB2, and CACNA2D cloned into pMirTarget vector (BlueHeron, USA) and contransfected or not with miR-21 mimic (hsa-miR-21-5p; MC10206), miRNA mimic negative control No. 1, or miR-21 inhibitor (MH10206; Life Technologies).
Western Blot Analysis
To measure Cav1.2 protein expression, a Western blot analysis in HL-1 cells transfected or not with miR-21 mimic was performed by using anti-Cav1.2 antibody (1:1000; Neuromab, USA).
Calcium Current Recordings
Currents were recorded in human atrial myocytes and HL-1 cells at room temperature using the whole-cell patch-clamp technique (micropipette resistance <3.5 MΩ). 5, 16 Series resistance was compensated manually and usually ≥80% compensation was achieved. Under our experimental conditions, no significant voltage errors (<5 mV) caused by series resistance were expected with the micropipettes used.
Statistical Analysis
Results are expressed as mean±SEM. Unpaired t test or 1-way analysis of variance followed by Newman-Keuls test was used where appropriate. In small-size samples (n<15), statistical significance was confirmed by using nonparametric tests. Comparisons between categorical variables were done using Fisher's exact test. To take into account correlations between multiple levels of within-patient measurements, data were analyzed with multilevel mixed-effects models. A value of P<0.05 was considered significant.
Additional details are presented in the Data Supplement.
Results
miR-21 Expression Levels Are Increased in Myocytes Isolated From Patients With CAF
We first compared the expression of miR-21 in myocytes enzymatically isolated from atrial appendages obtained from patients in SR (n=10) and with CAF (n=10) by qPCR. Figure 1A shows the ΔC t values corresponding to miR-21 levels measured in myocytes from patients in SR and with CAF. Importantly, miR-21 was expressed in human atrial myocytes from patients in SR, and as demonstrated by the comparison of the ΔC t values, miR-21 expression was significantly greater in CAF myocytes. Transformation of ΔC t to fold differences demonstrated that miR-21 expression was ≈3.8× greater in CAF than in SR myocytes ( Figure 1D ). Because decreased I Ca,L density is a hallmark of the CAF-induced electrical remodeling, 1,2 we measured CACNA1C and CACNB2 mRNA expression in isolated atrial myocytes from patients in SR and with CAF by qPCR. mRNA expression of the target genes was measured in the fractions of RNA >200 nucleotides obtained from the same human atrial myocyte samples used for miR-21 expression assay. The results demonstrated that CACNA1C and CACNB2 mRNA expression was ≈>60% and ≈>40%, respectively, in SR than in CAF myocytes . Interestingly, association studies demonstrated an inverse correlation of miR-21 expression with that of CAC-NA1C in patients in SR and with CAF ( Figure 1E ) and with I Ca,L density at +10 mV ( Figure 1F ), in such a way that the greater miR-21 expression, the lower CACNA1C expression and I Ca,L density. Therefore, we were interested in determining whether miR-21 could modulate the expression of Ca 2+ channel subunits. A computational analysis using several algorithms revealed CACNA1C and CACNB2 as potential targets for miR-21. Indeed, CACNA1C and CACNB2 3′UTR regions contain a sequence, which is complementary to the seed site of miR-21 (nucleotides 2-8; Figure I in the Data Supplement). On the contrary, 3′UTR region of CACNA2D did not exhibit any complementary sequence to the seed site of miR-21.
miR-21 Directly Binds to the 3′UTR of CACNA1C and CACNB2
To analyze whether miR-21 binds to the 3′UTR regions of the subunits forming the cardiac Ca 2+ channel, CACNA1C, CACNB2, and CACNA2D 3′UTR regions were cloned into pMirTarget vector, which contains firefly luciferase as a reporter. Cotransfection of miR-21 mimic (15-60 nmol/L) resulted in a concentration-dependent decrease of the luciferase activity in CHO cells transfected with CACNA1C and CACNB2 3′UTR regions compared with that measured in sham-transfected cells (Figure 2A and 2B). In both cases, miR-21 mimic at 30 nmol/L concentration reduced luciferase activity by >60%, and thus, this was the concentration selected for the rest of the experiments. The specificity of the miR-21 effect was supported by the absence of changes produced by the negative control miRNA (30 nmol/L). Furthermore, transfection of miR-21 inhibitor (antimiR-21; 30 nmol/L) significantly increased luciferase activity, demonstrating the relief of tonic repression by endogenous miR-21 in these cells. 17 As shown in Figure 2C , transfection of miR-21 mimic did not significantly modify luciferase activity in cells transfected with the CACNA2D 3′UTR region in accordance with the absence of any complementary sequence to the seed site of miR-21.
miR-21 Reduces the Density of L-Type Calcium Currents
qPCR experiments demonstrated that CAF myocytes displayed greater miR-21 expression than SR myocytes and that there was a correlation between I Ca,L density and miR-21 expression. We next compared properties of I Ca,L between SR and CAF by pooling recordings from 52 and 31 cells, respectively. Cell capacitance of CAF myocytes was greater than that of SR myocytes (77.9±5.6 versus 58.7±3.8 pF; P=0.005). Currents were recorded by applying 500-ms pulses from −80 mV to potentials between −40 and +50 mV in 5 mV increments, with a prepulse to −30 mV to inactivate the sodium current. Figure 3A and 3B show traces for I Ca,L recorded at +10 mV in SR and CAF myocytes and current density-voltage curves. As expected, I Ca,L density was significantly lower in CAF than in SR myocytes (−2.3±0.3 versus −3.3±0.3 pA/pF at +10 mV; P=0.016), whereas no differences in the activation and inactivation kinetics and voltage-dependent activation were observed. However, the midpoint of the inactivation curve was significantly shifted to more positive potentials ( Figure 3C and 3D; Table) . We next analyzed whether miR-21 transfection in HL-1 cells reproduced the effects on the I Ca,L induced by electrical remodeling. HL-1 cells exhibit functional L-and T-type Ca 2+ channels, and thus, both I Ca,L and I Ca,T can be recorded. HL-1 cells randomly patched were divided into 3 groups depending on the predominant voltage-gated Ca 2+ current recorded ( Figure  II in the Data Supplement). In control conditions (n=54), around 24% of cells did not exhibit any Ca 2+ current and ≈39% exhibited a large Ca 2+ current, identified as I Ca,T because it was completely abolished by NiCl (50 μmol/L) and reached its maximum density at −30 mV (I Ca,T -predominant cells; Figure  II in the Data Supplement). The rest of the cells (≈37%) exhibited a large I Ca,L that was abolished by nifedipine (1 μmol/L) and reached its maximum density at +20 mV ( Figure II Currents through L-type Ca 2+ channels were recorded in I Ca,L -predominant cells using Ba 2+ as the charge carrier (I Ba ). Figure 4A shows I Ba traces recorded by applying the protocol at the top transfected or not with miR-21 mimic (30 nmol/L). As can be observed in Figure 4B , current density reached its maximum value at +20 mV (n=30) and transfection of miR-21 mimic significantly reduced I Ba density (n=33; P=0.02) and slowed the time course of inactivation (P=0.005), without modifying activation kinetics ( Figure 4A-4C ; Table) . This I Ba density decrease could be attributed to the reduction of Cav1.2 expression produced by miR-21 as demonstrated by Western blot analysis ( Figure 5A and 5B). I Ba density was not modified by the negative control miRNA (30 nmol/L; n=15), but was significantly increased by antimiR-21 (30 nmol/L, n=15; Figure 4C ), demonstrating a tonic inhibition of I Ba by endogenous miR-21 in HL-1 cells. 18 miR-21 did not modify activation curves ( Figure 4D ) and shifted the midpoint of the inactivation curve to more positive potentials, without modifying the slope factor ( Figure 4D ; E rev indicates reversal potential; τ act , time constant of activation; τ f inact and τ s inact , fast and slow time constants, respectively, of current decay; V h and k, midpoint and slope, respectively, of the conductance voltage and availability curves. CAF, chronic atrial fibrillation; and SR, sinus rhythm.
*Activation kinetics was measured by fitting monoexponential functions to current traces recorded at +10 mV (human atrial myocytes) and +20 mV (HL-1). †Inactivation kinetics were measured by fitting biexponential and monoexponential functions to current traces recorded in human atrial myocytes (+10 mV) and HL-1 (+20 mV), respectively. ‡ and § P<0.05 vs SR and control values, respectively. Comparison between I Ca,L recorded from SR and CAF myocytes were made using multilevel mixed-effects models. Table) . Moreover, miR-21 did not significantly modify reactivation kinetics ( Figure III in the Data Supplement).
miR-21 Does Not Modify the Density of T-Type Calcium Currents
To determine whether the effects of miR-21 are specific to L-type Ca 2+ channel subunits, the consequences of miR-21 mimic transfection on I Ca,T were determined. In this group of experiments, only I Ca,T -predominant HL-1 cells were included for the analysis. As can be observed, miR-21 did not significantly modify I Ca,T density and time-and voltage-dependent properties ( Figure 6A and 6B ).
Discussion
The results presented here demonstrated that CAF upregulates miR-21 in human atrial myocytes, which, in turn, decreases I Ca,L , but not I Ca,T density.
miR-21 is Expressed in Human Atrial Myocytes and Is Upregulated by CAF
Our qPCR results demonstrated for the first time that miR-21 was expressed in enzymatically isolated atrial myocytes obtained from patients in SR. Some authors suggested that miR-21 was expressed in mouse and rat cardiac myocytes, where it could play a role in cardiac hypertrophy and in the protective effect of ischemic preconditioning against ischemia-induced cardiac myocyte damage. 19 On the contrary, other authors described that miR-21 was not expressed in mouse cardiac cells, 14 and thus, its role in cardiac remodeling produced in a pressure overload-induced mouse model was attributed to its presence in fibroblasts that affects cardiac myocytes in a paracrine fashion. 14 In human atria, miR-21 was found in whole atrial biopsies. 12, 20, 21 However, it is generally accepted that the presence of fibroblasts and nonmyocyte cells in whole biopsies complicates gene expression analysis. From our results, we suggest that, besides in fibroblasts, miR-21 is expressed in human atrial myocytes.
Our results also demonstrated that miR-21 expression was increased by 3.8-fold in CAF relative to SR myocytes. Expression of several miRNAs is reduced (eg, miR-1, miR-26, miR-29, miR-30, miR-133, miR-208, and miR-590) or increased (eg, miR-21, miR-328, miR-499, and miR-155) in atrial tissue collected from patients with AF relative to patients in SR. 22 Interestingly, CAF-induced increase of miR-21 expression has been a consistent finding in several studies, 12, 20, 21 being one of the most upregulated (3-to 4-fold) miRNAs. 20, 21 Adam et al 12 demonstrated that miR-21 upregulation was correlated positively with atrial collagen content and increased expression of profibrotic mediators. Therefore, miR-21 was considered to play a critical role in the structural remodeling associated with AF by means of an increased production of fibrosis. Indeed, atrial miR-21 knockdown suppressed atrial fibrosis and AF promotion in a rat model of myocardial infarction. 15 Several mechanisms could underlie AF-induced miR-21 expression increase involving post-transcriptional, nontranscriptional, and mainly transcriptional mechanisms. 23 In this regard, miR-21 gene is located on chromosome 17, in the 10th intron of the TMEM49 gene, although miR-21 is independently transcribed by its own promoter regions. 23 Nuclear factor κB expression increases in response to several stimuli (hypertrophy, oxidative stress, tumor necrosis factor-α, transforming growth factor-β, and the renin-angiotensin system) involved in structural and electrical AF-induced remodeling. 24 Moreover, an increase in nuclear factor κB expression/ activity under oxidative stress correlates with an increase in miR-21 expression, whose promoter region exhibits 5 nuclear factor κB binding sites. 25 Therefore, it can be speculated that increase in the nuclear factor κB expression/activity could be responsible, at least partially, of the increase in miR-21 expression observed in CAF patients.
miR-21 Regulates Calcium Channel Subunits Expression and Decreases I Ca,L
Decrease in the expression of the channels generating I Ca,L critically contributes to the abbreviation of APD and atrial refractory period. 2, 3 Our results demonstrated that there is an inverse correlation between miR-21 and CACNA1C expression and I Ca,L density, suggesting that miR-21 could target Ca 2+ channel subunits. This hypothesis was supported by the results yielded by the bioinformatic analyses. Alignment of CACNA1C and CACNB2 3′UTR sequences with miR-21 demonstrated a highly conserved 7mer interaction with the seed site of miR-21 and additional Watson-Crick base pairing matches near the seed site. It has been described that CAC-NA1C is a validated target for miR-1 and miR-328. 9,10 Importantly, both miRNAs are predicted to bind to 3′UTR sequence of CACNA1C with complementarity scores lower than those of miR-21. These predictions were confirmed by the concentration-dependent decrease in luciferase activity measured in cells transfected with the 3′UTR region of CACNA1C and CACNB2 produced by miR-21. The functional consequences of the interaction were demonstrated by the decreased expression of Cav1.2 protein in HL-1 cells transfected with miR-21. Importantly, patch-clamp studies demonstrated that miR-21 produced changes in I Ca,L properties qualitatively identical to those produced by CAF (ie, a marked reduction of I Ca,L density and shifts of the inactivation curves to more depolarized potentials). Current density reduction may be attributed to miR-21 effects on CACNA1C expression. However, voltagedependent effects would not be expected from the decrease in the expression of the α-subunit and could be attributed to the repression of CACNB2. Our results confirmed previous data showing that miR-21 decreased luciferase activity generated by cells transfected with 3′UTR of CACNB2. 26 Thus, considering that coexpression of Cavβ2 with Cav1.2 subunits leads to a substantial increase in I Ca,L density and a shift of the inactivation curves to more hyperpolarized voltages, 27 it is reasonable to propose that the voltage-dependent effects produced by miR-21 could be mediated by the decrease in CACNB2 expression. However, it cannot be ruled out that the presence of ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid in the internal solution can be partially responsible of these voltage-dependent effects, as was proposed previously, 28 even when miR-21 effects on I Ca,L were similar under ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid-free conditions ( Figure IV in the Data Supplement). To determine the specificity of the interaction, HL-1 cells were transfected with an miRNA mimic negative control, which is a random sequence miRNA mimic molecule with no predicted targets or with an miR-21 inhibitor that specifically binds to and inhibits endogenous miR-21. The absence of effects of miRNA mimic negative control confirmed that miR-21 effects were caused by its interaction with the 3′UTR of the channel subunits. On the contrary, miR-21 inhibitor increased I Ca,L density, suggesting that endogenous miR-21 was producing a tonic inhibition of the current that was relieved by the inhibitor. Further support came from the fact that miR-21 did not modify I Ca,T , in accordance with the absence of complementarity between miR-21 and the 3′UTR of CACNA1G, CACNA1H, and CAC-NA1I, which encode the 3 types of α-subunits responsible for I Ca,T (Cav3.1, Cav3.2, and Cav3.3).
Reduction of I Ca,L density by CAF has been consistently described in patients, 2, 3, 6, 7, 16 as well as in AF experimental models, 4 and it has been proposed to be triggered by Ca 2+ overload secondary to the rapid atrial rates. 29 The molecular mechanisms underlying I Ca,L downregulation are complex and can include impaired Cav1.2 protein trafficking induced by a zinc-binding protein, activation of the Ca 2+ /calmodulin/calcineurin/nuclear factor of activated T cells system causing transcriptional downregulation of the Cav1.2 α-subunit, Ca 2+ channel dephosphorylation because of serine/threonine protein phosphatase activation, enhanced Cav1.2 α-subunit S-nitrosylation, activation of calpains, ankyrin-B dysfunction, or impaired src kinase activity. 2, 30, 31 Besides all these mechanisms, it has been recently proposed that miRNAs could be involved in AF-induced I Ca,L downregulation. 10, 22 Among all the miRNAs that are upregulated in patients with CAF, only miR-328 has been described to regulate Ca 2+ channel α1c and β subunits expression. 10 miR-328 is increased in right atrial appendages from patients with CAF relative to those in SR. Moreover, overexpression of miR-328 through adenoviral infection in canine atrium and transgenic manipulation in mice enhanced AF susceptibility, decreased I Ca,L density, and shortened atrial APD as a result of the repression of CACNA1C expression. It has been described that other miRNAs, such as miR-1 or miR-26 whose expression is decreased in AF, play a role in the AF-induced electrical remodeling, mainly by targeting Kir2.1 channels. 32, 33 Both miRNAs are involved in the AF-induced increase of the inward rectifier current and, thus, in the shortening of the APD. Therefore, it can be proposed that all these miRNAs (miR-1, miR-21, miR-26, and miR-328) may contribute to AF-induced electrical remodeling and eventually to the perpetuation of the arrhythmia.
Our study provides the first description of a putative involvement of miR-21 in the modulation of I Ca,L and a potential mechanism linking structural and electrical remodeling processes. Recent evidence suggests that structural and electrical remodeling processes may not be independent and would share some common pathways. 34, 35 In fact, it has been demonstrated that activation of fibrotic signaling pathways via soluble cytokines, such as TGF-β1 and platelet-derived growth factor, modulate Na + , Ca, 2+ and K + currents involved in the control of atrial APD. 34, 35 
Study Limitations
All samples came from right atrial appendages, which could not be representative of the rest of the atria. Furthermore, miR-21 and Ca 2+ channel subunits expression could be influenced by age, pharmacological treatment (it has been shown that statin treatment reduces miR-21 expression), 12 sex, and underlying cardiac diseases of the patients. The proportion of patients with ischemic heart disease alone and combined with valvular cardiopathy or under statin therapy were equally distributed in both groups, indicating that the changes described here could be attributed to CAF itself.
Conclusions
Our results demonstrated that miR-21 expression increases in myocytes isolated from patients with CAF. Moreover, it decreases I Ca,L density by downregulating Ca 2+ channel subunits expression. These results suggested that miR-21 could participate in the CAF-induced I Ca,L downregulation and in the APD shortening that maintains the arrhythmia.
